
SciDaVis
RJS Graph
OriginPro
DataMelt
GnuPlot
Aveloy Graph
IGOR Pro
LabPlot is a KDE-application for interactive graphing and analysis of scientific data.

Which is more popular?
Based on our record, Figma seems to be more popular. It has been mentioned 114 times since March 2021.
Website, pricing, platforms and company facts side by side.
|
|
|
|
|---|---|---|
| Website | labplot.org | figma.com |
| Pricing | — | |
| Company | 2024 | Startup from the United States |
| Listed in |
In their own words, as submitted to SaaSHub.


LabPlot is a FREE, open source and cross-platform Data Visualization and Analysis software accessible to everyone and trusted by professionals. FEATURE HIGHLIGHTS High-quality data visualization and interactive plotting Data analysis, statistics, nonlinear regression, curve and peak fitting Fast...
No description of Figma yet.
What each product offers, as listed by its team.


Possible disadvantages
Possible disadvantages
An editorial look at what each product does well and who it suits.


No analysis of LabPlot yet.
Overall verdict
Why this product is good
Recommended for
Walkthroughs and reviews on video.
How to fit a curve using LabPlot
More videos
Figma UI Design Tutorial: Get Started in Just 24 Minutes!
More videos
How often each product is chosen within a category, 0–100% relative to the other.


Share your experience with using LabPlot and Figma. For example, how are they different and which one is better?
External articles and on-site reviews we used to compare the two products.


LabPlot provides extensive capabilities for data import and export, along with tools for analysis, curve fitting, nonlinear regression and interactive visualization, including live data support. Users can export...
My favorite tool right now.
Figma is a tool that almost everyone has heard about, whether you are a designer, programmer, or marketer. However, for those unfamiliar with Figma, it is a flexible web design platform that allows real-time teamwork...
Figma is the preferred tool of many professionals in the field of interactive design, real prototyping and graphic design. Figma simplifies and speeds up the brainstorming process with its online whiteboards and...
Recommendations tracked on public social media and blogs since March 2021.


Tracking LabPlot since Mar 2021.
Category Tool URL How I used it General AI assistant ChatGPT Https://chatgpt.com Breaking down concepts, simulating interviewers, reviewing answers AI writing / reasoning Claude Https://claude.ai Refining behavioral stories and... - Source: dev.to / 5 months ago
Figma is the most widely used sketching tool in the industry and has a generous free tier. - Source: dev.to / 6 months ago
Design Tools (152 EUR/month): Adobe Creative Cloud at 63 EUR, Maxon One at 50 EUR, Figma at 15 EUR, Spline at 7 EUR, Envato Elements at 17 EUR. This is where the real money goes. Adobe alone is a third of my total design spend. - Source: dev.to / 6 months ago
When comparing LabPlot and Figma, you can also consider the following products.

SciDAVis is a free application for Scientific Data Analysis and Visualization.
Compare SciDaVis to LabPlot or Figma:

Canva is a graphic-design platform with a drag-and-drop interface to create print or visual content while providing templates, images, and fonts. Canva makes graphic design more straightforward and accessible regardless of skill level.
Compare Canva to LabPlot or Figma:

RJS Graph is an artificial intelligence-based data management platform that allows users or developers to organize the data by manipulating the binaries, scientific, mathematical, and other insights with accurate results.
Compare RJS Graph to LabPlot or Figma:

Adobe XD is an all-in-one UX/UI solution for designing websites, mobile apps and more.
Compare Adobe XD to LabPlot or Figma:

OriginLab OriginPro is a comprehensive interface-based data management platform that allows users to calculate or visualize the data insights in various fields like engineering, scientific domain, or multi-sector industrial stats.
Compare OriginPro to LabPlot or Figma:
